{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:39:57Z","timestamp":1788316797654,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T00:00:00Z","timestamp":1724544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T00:00:00Z","timestamp":1724544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10067-024-07118-9","type":"journal-article","created":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T13:01:46Z","timestamp":1724590906000},"page":"3213-3221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0264-7284","authenticated-orcid":false,"given":"Koc Emine","family":"Rabia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9477-5031","authenticated-orcid":false,"given":"G\u00fcll\u00fc","family":"Gizem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5945-2317","authenticated-orcid":false,"given":"Saridas","family":"Furkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9230-9093","authenticated-orcid":false,"given":"Gluscevic","family":"Sanja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0298-4157","authenticated-orcid":false,"given":"Coskun Belk\u0131s","family":"Nihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-8836","authenticated-orcid":false,"given":"Pehlivan","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6644-6553","authenticated-orcid":false,"given":"Calikusu Fatma","family":"Zehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6752-1519","authenticated-orcid":false,"given":"Turan Omer","family":"Faruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,25]]},"reference":[{"key":"7118_CR1","first-page":"1152","volume":"105","author":"H Behcet","year":"1937","unstructured":"Behcet H (1937) Uber rezidivierende, aphthose, d\u00fcrchein Virus verursachteGeshwure am Munde, am Auge und an den Genitalien. Dematologische Wochenschrift 105:1152\u20131157","journal-title":"Dematologische Wochenschrift"},{"key":"7118_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5152\/eurjrheum.2020.20095","volume":"8","author":"YB Turgut","year":"2021","unstructured":"Turgut YB, Sargin G (2021) A study of the use of Beh\u00e7et\/Beh\u00e7et\u2019s disease or syndrome with or without Adamantiades in the medical literature during the past two decades. Eur J Rheumatol 8:84\u201388. https:\/\/doi.org\/10.5152\/eurjrheum.2020.20095","journal-title":"Eur J Rheumatol"},{"key":"7118_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/BOR.0000000000000562","volume":"31","author":"U Uyguno\u011flu","year":"2019","unstructured":"Uyguno\u011flu U, Siva A (2019) Nervous system involvement in Beh\u00e7et\u2019s syndrome. Curr Opin Rheumatol 31:32\u201339. https:\/\/doi.org\/10.1097\/BOR.0000000000000562","journal-title":"Curr Opin Rheumatol"},{"key":"7118_CR4","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","volume":"261","author":"S Kalra","year":"2014","unstructured":"Kalra S, Silman A, Akman-Demir G et al (2014) Diagnosis and management of Neuro-Beh\u00e7et\u2019s disease: international consensus recommendations. J Neurol 261:1662\u20131676. https:\/\/doi.org\/10.1007\/s00415-013-7209-3","journal-title":"J Neurol"},{"key":"7118_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/ard.62.3.280","volume":"62","author":"G Licata","year":"2003","unstructured":"Licata G (2003) Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behcet\u2019s syndrome. Ann Rheum Dis 62:280\u2013281. https:\/\/doi.org\/10.1136\/ard.62.3.280","journal-title":"Ann Rheum Dis"},{"key":"7118_CR6","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/1756-185X.14209","volume":"24","author":"D YalcinKehribar","year":"2021","unstructured":"YalcinKehribar D, Gunaydin S, Ozgen M (2021) Infliximab therapy in parenchymal neuro-Beh\u00e7et\u2019s disease: a single-center experience. Int J Rheum Dis 24:1302\u20131307. https:\/\/doi.org\/10.1111\/1756-185X.14209","journal-title":"Int J Rheum Dis"},{"key":"7118_CR7","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1212\/NXI.0000000000000258","volume":"3","author":"B Zeydan","year":"2016","unstructured":"Zeydan B, Uygunoglu U, Saip S et al (2016) Infliximab is a plausible alternative for neurologic complications of Beh\u00e7et disease. Neurol Neuroimmunol Neuroinflamm 3:e258. https:\/\/doi.org\/10.1212\/NXI.0000000000000258","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"7118_CR8","doi-asserted-by":"publisher","first-page":"300060523116989","DOI":"10.1177\/03000605231169895","volume":"51","author":"RHA Mohammed","year":"2023","unstructured":"Mohammed RHA, Woldeamanuel YW (2023) The effectiveness of the anti-tumor necrosis factor therapy infliximab in neuro-Beh\u00e7et\u2019s disease: a systematic review and meta-analysis. J Int Med Res 51:3000605231169895. https:\/\/doi.org\/10.1177\/03000605231169895","journal-title":"J Int Med Res"},{"key":"7118_CR9","doi-asserted-by":"publisher","unstructured":"Wang X, Liu Y, Ao Y, et al (2024) Infliximab for parenchymal neuro-Beh\u00e7et\u2019s syndrome: case series and meta-analysis. Clin Exp Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/5lnkd4","DOI":"10.55563\/clinexprheumatol\/5lnkd4"},{"key":"7118_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s11940-011-0120-2","volume":"13","author":"G Akman-Demir","year":"2011","unstructured":"Akman-Demir G, Saip S, Siva A (2011) Beh\u00e7et\u2019s disease. Curr Treat Options Neurol 13:290\u2013310. https:\/\/doi.org\/10.1007\/s11940-011-0120-2","journal-title":"Curr Treat Options Neurol"},{"key":"7118_CR11","doi-asserted-by":"publisher","first-page":"152206","DOI":"10.1016\/j.semarthrit.2023.152206","volume":"61","author":"J Sota","year":"2023","unstructured":"Sota J, Capuano A, Emmi G et al (2023) Therapeutic approach to central nervous system involvement of Beh\u00e7et\u2019s disease. Semin Arthritis Rheum 61:152206. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152206","journal-title":"Semin Arthritis Rheum"},{"key":"7118_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva A, Kantarci OH, Saip S et al (2001) Behcet\u2019s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248:95\u2013103. https:\/\/doi.org\/10.1007\/s004150170242","journal-title":"J Neurol"},{"key":"7118_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/art.23345","volume":"59","author":"N Pipitone","year":"2008","unstructured":"Pipitone N, Olivieri I, Padula A et al (2008) Infliximab for the treatment of neuro-Beh\u00e7et\u2019s disease: a case series and review of the literature. Arthritis Rheum 59:285\u2013290. https:\/\/doi.org\/10.1002\/art.23345","journal-title":"Arthritis Rheum"},{"key":"7118_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00296-009-1213-z","volume":"31","author":"A Giardina","year":"2011","unstructured":"Giardina A, Ferrante A, Ciccia F et al (2011) One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Beh\u00e7et\u2019s disease refractory to standard immunosuppressive drugs. Rheumatol Int 31:33\u201337. https:\/\/doi.org\/10.1007\/s00296-009-1213-z","journal-title":"Rheumatol Int"},{"key":"7118_CR15","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1093\/rheumatology\/keac097","volume":"61","author":"A Herrero-Morant","year":"2022","unstructured":"Herrero-Morant A, Mart\u00edn-Varillas JL, Casta\u00f1eda S et al (2022) Biologic therapy in refractory neurobeh\u00e7et\u2019s disease: a multicentre study of 41 patients and literature review. Rheumatology (Oxford) 61:4427\u20134436. https:\/\/doi.org\/10.1093\/rheumatology\/keac097","journal-title":"Rheumatology (Oxford)"},{"key":"7118_CR16","first-page":"68","volume":"40","author":"MA Meliko\u011flu","year":"2008","unstructured":"Meliko\u011flu MA, Meliko\u011flu M (2008) The influence of age on Behcet\u2019s disease activity. Eurasian J Med 40:68\u201371","journal-title":"Eurasian J Med"},{"key":"7118_CR17","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. International study group for Beh\u00e7et\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"7118_CR18","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/art.38351","volume":"66","author":"N Noel","year":"2014","unstructured":"Noel N, Bernard R, Wechsler B et al (2014) Long-term outcome of neuro-Beh\u00e7et\u2019s disease. Arthritis Rheumatol 66:1306\u20131314. https:\/\/doi.org\/10.1002\/art.38351","journal-title":"Arthritis Rheumatol"},{"key":"7118_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2169\/internalmedicine.1969-23","volume":"63","author":"S Hirohata","year":"2024","unstructured":"Hirohata S, Kikuchi H, Sawada T et al (2024) Effect of infliximab on chronic progressive neuro-Beh\u00e7et\u2019s disease: influence of the timing of introduction on the patient outcome. Intern Med 63:481\u2013486. https:\/\/doi.org\/10.2169\/internalmedicine.1969-23","journal-title":"Intern Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07118-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07118-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07118-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T20:25:33Z","timestamp":1728937533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07118-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,25]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["7118"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07118-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,25]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Our study received ethical approval from our university ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and dissemination"}}]}}